Subsequent Events |
3 Months Ended |
|---|---|
Mar. 31, 2024 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | Subsequent Events Our significant events subsequent to March 31, 2024 were as follows: Collateralized Loan Obligations In May 2024, we refinanced a $400 million pool of our infrastructure loans held-for-investment through a CLO, STWD 2024-FL3, with $330 million of third party financing at a weighted average coupon of SOFR + 2.18%. The CLO contains a reinvestment feature that, subject to certain eligibility criteria, allows us to contribute new loans or participation interests in loans to the CLO for a period of three years. Refinancing of Medical Office Portfolio In May 2024, we priced the refinancing of $600.0 million of outstanding debt on our Medical Office Portfolio due November, 2024 with $450.5 million of senior securitized mortgage debt and a $39.5 million mezzanine loan. The refinance proceeds will carry an initial term of two years, followed by three successive one-year extension options and a weighted average coupon of SOFR + 2.52%.
|